Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 16,500
-400 (-2.37%)
Aug 12, 2026, 1:45 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 169.1 billion as of August 11, 2026. Its market cap has decreased by -31.58% in one year.
Market Cap
169.10B
Enterprise Value
126.42B
Revenue
8.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,500.00
ChartMarket Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 169.10B, a decrease of -42.05%. That is a compound annual growth rate of -5.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 164.20B | -64.97% |
| Dec 30, 2025 | 468.79B | 155.02% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 230.67B |
| BINEX | 221.02B |
| EASY BIO,Inc. | 214.37B |
| HLB Therapeutics | 211.06B |
| Bioneer | 186.61B |
| JETEMA, | 169.66B |
| Helixmith | 165.08B |
| NeoImmuneTech | 150.67B |